COX-2 Conundrum

Intended Audience
This activity is designed for physicians, NPs, PAs, and nurses with a special interest in the treatment of pain and arthritis with COX-2 selective NSAIDs and traditional NSAIDs.

Statement of Need
Things have changed. Vioxx® (rofecoxib) is no longer available. What does this mean for you and your patients and what are the options now? Understand the tradeoffs in cardiovascular risk, GI safety and clinical effectiveness of NSAIDs.

Learning Objectives: Participants completing this program will:

1. Explore NSAID and non-NSAID pain relief options available now
2. Review cardiac adverse events with COX-2s
3. Identify the key questions for deciding NSAID therapy
4. Evaluate who needs aspirin for cardioprotection
5. Distinguish the risks and benefits of aspirin therapy
6. Identify which patients are at risk for gastric ulcers and discuss which patients need gastroprotection
7. Identify strategies to prevent NSAID gastropathy
8. Evaluate how to weigh CV and GI risk to decide on pain relief and gastroprotection options

Method of Participation
This slide presentation with audio should take approximately 1 hour to complete. The participant should:
1) Read the objectives and other introductory information.
2) Listen to the approximately 1 hour of audio while viewing the 42 slides. Please note that this program was recorded and as a result, participants will not have the opportunity to ask questions of the presenter.
3) Take the post-test. The post-test can be accessed by clicking on the post-test icon that follows the presentation.
4) Login and complete the evaluation and registration information.
5) Participants who complete the post-test and evaluation will be issued a CME/CE certificate, which may be printed at their location. A database of certificates awarded online is maintained at the Dannemiller Foundation. No additional certificate will be mailed. Expiration date for credit is January 31, 2006.

Accreditation and Designation
Physicians:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Dannemiller Memorial Educational Foundation and The Customer Link. The Dannemiller Memorial Educational Foundation is accredited by the ACCME to provide continuing medical education for physicians.

The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Pharmacists:
Purdue University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. This is a continuing education activity of Purdue, an equal access/equal opportunity university. To receive the 1 contact hour of continuing education credit, pharmacists should complete the activity requirements and evaluation at the conclusion of the web-on-demand program. Approval is valid from the initial release date of November 15, 2004. The expiration date is January 31, 2006. Program # 018-999-04-084-H01.

Nurse Practitioners:
This program has been approved for 1.2 contact hours of continuing education (which includes 1.2 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0410404.

Nurses: The Dannemiller Memorial Educational Foundation is an approved provider of the California Board of Registered Nursing. Provider approved by the California Board of Registered Nursing, Provider Number 4229 for 1.2 contact hours.

RNs outside California must verify with their licensing agency for approval of this course.

Disclosure of Unlabeled or Investigational Drugs
It is the policy of the Dannemiller Memorial Educational Foundation that faculty disclose any unlabeled or investigational drugs discussed in their presentation. Any such disclosure will be made during the presentation when these drugs are first discussed.

Faculty Disclosure
The Dannemiller Memorial Educational Foundation requires that the faculty participating in a continuing medical education activity disclose to Participants any significant financial interest or other relationship (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation, and (2) with any commercial supporters of the activity. Dr. Fendrick reported that he serves as a consultant and speaker for TAP Pharmaceutical Products, AstraZeneca, Merck, McNeil, and Procter and Gamble.

Off Label Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of the Dannemiller Memorial Educational Foundation, Tap Pharmaceutical Products Inc., or The Customer Link, Inc.  This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter.  Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.

Contact Information
For questions regarding the content of this activity, please contact the Dannemiller Educational Memorial Foundation, accredited provider for this activity at kendrab@dannemiller.com. For technical assistance, please e-mail info@gicme.com

Hardware/Software Requirements
GIcme.com requires version 5.x or higher for Microsoft Internet Explorer or Netscape 6 or higher for your internet browser. Additionally, Macromedia Flash Player MX is required to view this website. Certain areas or educational activities available on this site may require additional software or hardware to view the content. Areas or activities requiring the use of additional software or hardware will be indicated in the introduction for the activity and, when appropriate, will be linked to the required software so it can be downloaded. Examples of software that may be required include Flash, Adobe Acrobat. If you encounter problems using this site or have problems obtaining or downloading software required to view any portion of this site, please notify us at info@gicme.com.

This activity is jointly sponsored by the Dannemiller Memorial Educational Foundation and The Customer Link, Inc.

This activity is supported by an educational grant from TAP Pharmaceutical Products Inc.

Privacy Policy